Genomic assay

Details for Australian Patent Application No. 2005286084 (hide)

International Classifications

Event Publications

10 May 2007 PCT application entered the National Phase

PCT publication WO2006/033088 Priority application(s): WO2006/033088

28 April 2011 Application Accepted

Published as AU-B-2005286084

4 August 2011 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 13 Jul 2011. Address for service in Australia - Phillips Ormonde Fitzpatrick 367 Collins Street Melbourne VIC 3000 2005307744 3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto Arena Pharmaceuticals, Inc. The nature of the amendment is as shown in the statement(s) filed 14 Jul 2011. Address for service in Australia - FB Rice Level 23 44 Market Street Sydney NSW 20

24 November 2011 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 13 Jul 2011

12 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.